How is prostate cancer treated in Israel

+ 972 3 374 15 50

Prostate cancer treatment in Israel and its cost

You can choose an uncompromising option of treatment and accurate examination from 2-5 thousand dollars. There are several options for treatment tactics, depending on age and the need to preserve erectile function; in elderly patients, observation is often chosen. After all, this type of cancer usually develops slowly and does not bother the patient for a long time.

The cost of treatment with us is from 5 to 12 thousand dollars or more. In case of aggressive development of the disease, radical methods of treatment are chosen. Let's talk about it.

Israel treats Prostate cancer no worse than America. After all, the methods are the same. Doctors often do too. Want to get a free consultation from an Israeli specialist

Our doctors

Professor Lieberman, from the USA, once said: if a patient is diagnosed with prostate cancer today, then with a probability of 70% he will meet the New Year five times. If you do a normal operation, then there are chances in 70% of cases to celebrate the New Year 10 times, if you manage to do radiation therapy, then it will be 12 New Year holidays. If you add hormone therapy, then you can not count the holidays, but there may be problems with sex. We offer the most effective option, but at the same time, the most economical. Compare our offer with others. If it turns out to be too expensive for you, then we can offer you a compromise option from 5 thousand. But ask us for this option.

In the treatment of prostate cancer in Israel, of course, the patient's quality of life is at the forefront of the issue when choosing a strategy. Write to us to receive an individual program.

The treatment of the disease is exhaustively described in this material. You will be able to choose a doctor and medical institution. All the best resources of Israeli medicine in this field are indicated here. The cost of prostate cancer treatment in Israel starts from 12 thousand dollars, details and terms are given below.

Israel treats prostate cancer in such a way that, according to official statistics, the survival rate for this disease in recent years has been more than 93%, and this is an excellent result. So you can be sure that you have done everything possible if, having contacted us, you have chosen our group of doctors, because they are the best.

But if you want an economical treatment option in a public hospital, at the lowest price of prostate cancer treatment in Israel, then we can offer it to you, with payment to the cashier, with treatment directly, without intermediaries

If you want to get the best choice, then we will offer you three to choose from. And it will be the best we have in the country.

Leading surgeon Alex Tsivyan, Acting Head of the Department of the Rabin Hospital (Beilinson Medical Center), operates in Assuta,

Professor Jacques Baniel, oncourologist, who most citizens wish to be treated by,

Dr. Zohar Dotan (Urooncological Surgeon), Head of Department at Tel Aviv State Hospital,

Dr. Andrey (Anzhey) Nado (surgeon-uro-oncologist), head of the department at the hospital in Petah Tikva,

Lead Surgeon Avi Beri,

Professor Ofer Merimsky, oncologist,

Professor Moshe Inbar, Chief Oncologist,

Prof. Baruch Klein, oncologist,

Yuza Hen and other doctors involved in the complex treatment of prostate cancer.

Diagnosis of prostate cancer

- Detailed blood tests (general blood count, biochemistry, lipids, hormonal profile, tumor markers, total and free PSA, electrolytes) and urine (general, biochemistry, culture) 670;

- option of ultrasound of the genitourinary system with the determination of residual urine 390;

- Revision of the previous biopsy (if performed) 680;

- Consultation of uro-oncologist 500.

- Option radioisotope examination of bones (623)

- Options: PET CT with choline (from 1000), MRI, TRUS (284), CT of three cavities (850).

But, here and below, prices for prostate cancer treatment in Israel may change due to changes in the price list.

All examinations are carried out within 3-4 business days.

The cost of a prostate examination in Germany in a leading clinic in Bavaria is 50% higher

Our services in the organization of treatment

In the treatment of prostate cancer in Israel, our consultation center offers patients:

The widest choice of leading doctors, which is impossible to do just in a hospital

With payment to the cash desk of the hospital of your choice at its rates

High-quality support and translation, which are mandatory for the hospital

Only the international department of the clinic and leading top doctors deal with your application

Prostate cancer treatment prices

Prostate cancer treatment in Israel in our clinic consists of 4 packages, see below! The cost of the examination is $4,000. The cost of the operation is from 10 thousand dollars (there is an option for 5 thousand for you), radiotherapy in combination with hormone therapy is over 12 thousand dollars.

You can trust us. Your contact will be only with the doctors of the clinic, no agents, all actions under the contract. Prices for the treatment of prostate cancer in Israel, we have fixed, but may vary somewhat over time. The price of the operation depends on the type, participation of a top surgeon, and the choice of clinic. Payment only to the cashier of the clinic, according to the prices of the clinic and even lower. Advance payment is not required. Accompaniment for a week costs from $240 and includes direct accompaniment to medical events, interpretation and translation.

Assuta Clinic

On the basis of the Assuta clinic, they diagnose adenomas, adenocarcinomas, but how to organize this whole process in a clinic if it has about five hundred counterparties and it works only through them. In Israel, there are several leading doctors specializing in this problem. How to choose them.

He has rich practical experience in Israel and the USA. We have a great positive experience of cooperation with this doctor. As mentioned above, there are several treatment strategies for the doctor and the patient. An increasingly fashionable choice in the world is the observation of an elderly patient. The researchers found that autopsies on a large number of older men found prostate cancer, despite the fact that patients were not treated for it, and did not know about it. In most cases, the disease does not manifest itself in any way, and the person dies from other health problems. In such a case, active intervention would harm the patient, seriously impairing his quality of life.

Treatment options:

Examination does not give an unequivocal answer about the type of tumor (for example, the patient did not bring glasses and blocks from a previous biopsy, or the biopsy was of poor quality), and a transrectal ultrasound-guided prostate biopsy is required. Cost from $1,500 including pathology report. After that, you have to wait for an operation or a decision on another tactic for 5-6 days.

Examination makes it possible to apply a specific treatment tactic - one of the packages below. But for absolute accuracy, you can visit consultations with various specialists, however, you have already visited a specialist in your homeland.

The central attending physicians for our patients are the head of the department of urological oncology of the Tel Hashomer Hospital (Sheba), Dr. Zohar Dotan. Operations are carried out on the basis of the newest Assuta hospital, where, in addition to the most modern equipment, excellent living conditions are created for patients.

This and other attending physicians are of the highest caliber. In the application, you can indicate the desired attending physician, or request his resume.

Prostate cancer treatment in Israel

Prostate cancer treatment in Israel is one of the most successful in the world. The success of Israeli oncology in the treatment of this disease is explained by the extensive experience of Israeli medicine in this area. High life expectancy in Israel leads to an increase in the number of cases of prostate cancer, and Israeli doctors perform a lot of surgical operations on the prostate gland at various stages of the disease, have extensive practical experience in using modern methods of chemotherapy, hormone therapy, targeted and radiation therapy.

In the early stages, a complete cure in the treatment of prostate cancer in Israel is achieved in 98% of cases. At advanced stages, it is also possible to stop the malignant process, a significant increase in life expectancy without loss of its quality. When a malignant tumor goes beyond the prostate, in 50% it is possible to completely remove it surgically. In all other cases, the outcome of the disease is determined by chemotherapy and radiation therapy.

The treatment of urological pathologies, in particular, the treatment of prostate cancer and the treatment of testicular cancer in Israel, is carried out in our medical center by professors Avishai Sela and Amnon Zisman. Both professors are included in the annual list of the best doctors in Israel, are the authors of many scientific papers and have extensive practice.

Causes of illness

Modern oncology cannot unequivocally answer the question about the causes of pathology, but in the treatment of prostate cancer in Israel, all risk factors are taken into account:

• The testosterone hormone has been suggested to play a large role in this disease.
• The disease can also be caused by gene mutations that occur in old age. In most cases, the disease occurs after 65 years.
• Being overweight is a significant risk factor for PCa.
• Heredity, as the cause of the disease, can be traced in 5-10%.

Diagnosis of prostate cancer in Israel

Israeli scientists have put a lot of effort into creating ultra-precise and ultra-modern technologies that allow detecting oncological pathology at the earliest stages of its development.

Diagnosis in the treatment of prostate cancer in Israel at stages 3 and 4 is not difficult, but in the early stages, a malignant tumor in the prostate gland is rarely detected, since the growth of a malignant tumor often occurs in the complete absence of symptoms.

The Asaf ha Rofé clinic uses modern methods for diagnosing prostate cancer, which allow you to determine the type and size of the formation, pathological severity, the exact localization of the malignant focus, the presence of a metastatic process, and also diagnose the general condition of the patient.

It is possible to undergo all diagnostic procedures in the treatment of prostate cancer in Israel within 3-4 days. Examination for prostate cancer consists of several stages.

• First of all, this is a consultation of the patient by a urologist (rectal examination) and an oncologist. The cost of an oncologist consultation is $550.
• Laboratory blood and urine tests, including PSA tumor marker. This analysis is ambiguous, and the interpretation of its results requires a lot of experience of the doctor. There are many cases of both false positives and false negatives.
• PET PSMA is by far the most accurate test to assess the extent of prostate cancer in the body.

PSA - prostate specific antigen - is a highly discussed tumor marker in modern oncology. There are many pros and cons to using this diagnostic method. But still, more researchers are inclined to believe that the PSA test is a good method for monitoring prostate adenoma and prostate cancer. It is also used for intermediate diagnosis at different stages of treatment.

Biopsy. A mandatory diagnostic method when a neoplasm is detected during a rectal examination or with an elevated PSA level. Tissue sampling for research is carried out using transrectal ultrasound from two or more sites to obtain a complete picture. The imaging stage of diagnosing a prostate tumor consists in performing an ultrasound transurethral examination (250) and computed tomography (the cost of an image of one section is 670). If necessary, radiography (100), magnetic resonance imaging (1300), transrectal interventional magnetic resonance imaging, skeletal scintigraphy (850) and mandatory biopsy (1850) may also be performed. The results of diagnosis, the nature of the tumor are assessed on the Gleason scale, from 1 to 10. The first stage is the most favorable in terms of prognosis. The treatment of prostate cancer in Israel is based on the results of the diagnosis, and the set of procedures is selected individually.

Sign up for treatment

Methods of treating prostate cancer in Israel

After receiving the results of the examination, we can talk about the most appropriate treatment for prostate cancer. It usually requires an integrated approach and combines traditional and innovative therapy technologies. In total, cancer treatment in Israel, which is more affordable than in the US and Germany, has reached the heights and is now considered one of the most effective in the world.

Surgical treatment of prostate cancer

The standard treatment for prostate cancer in Israel has improved significantly over the past decade. Thus, surgical methods of therapy were replenished with various microsurgical technologies (for example, laparoscopy), which made surgical treatment safer and less traumatic. As a result, the number of postoperative complications and side effects has decreased.

Surgical treatment of prostate cancer at an early stage involves the removal of only the tumor, so the prostate itself remains intact and all its functional abilities are preserved. The cost of laparoscopic surgery is about 25 thousand dollars. However, in advanced prostate cancer, radical removal of the prostate and testicles may be required. The cost of radical prostatectomy is around $18,000

There are several ways to carry out this operation - retropubic or perineal - the most common types. During them, the prostate itself, seminal capsules and part of neighboring tissues are removed. This operation is quite complicated, sometimes it takes up to 4 hours, sometimes it has some complications - impotence, narrowing of the urethra, urinary incontinence.

For elderly patients with small tumors, a less invasive method is preferable - transurethral resection of the prostate (TURP). Depending on the type of tumor and the complexity of the case, a group of experienced specialists selects the method of surgical treatment.

Over the past five years, and at the Asaf ha Rofe Medical Center, the method of robotic prostatectomy using the Da Vinci robot has been widely used for prostate cancer.This method has established itself as the least traumatic of all currently existing types of prostate cancer treatment in Israel. Its only drawback is the high cost. Robotic prostatectomy costs about $35,000.

Radiation therapy

In radiation therapy, several methods can be used - remote external exposure, brachytherapy, injections of radioactive drugs. Methods for conducting external beam therapy in Israel are constantly being improved. Irradiation sessions last a few minutes every day for 5-7 weeks. Modern devices for radiation therapy allow you to irradiate the tumor from different angles, with the regulation of radiation intensity. Modern accelerators, equipped with the Rapid-Arc system, allow intensive irradiation of only affected tissues.

Injections with radioactive drugs are used when it is impossible to carry out conventional radiation therapy, but this type of prostate cancer treatment in Israel is not suitable for all tumors.

Brachytherapy

One of the treatments for prostate cancer is brachytherapy. The method involves irradiating the tumor from the inside. Over the years it has become clear that the method has irreversible side effects. The Asaf ha Rofe Hospital decided not to use this technique in the treatment of prostate cancer.

Hormonal treatment

The treatment of prostate cancer with the use of hormone correction is recognized as highly effective. However, this type of therapy can be prescribed only after the patient has undergone a complete comprehensive examination and confirmation that this method will be effective in a particular case. As a rule, in the treatment of prostate cancer in Israel, hormone therapy is prescribed in combination with radiotherapy at the 3rd stage of the disease, or as the main treatment for the 4th stage of the disease.

If during the laboratory diagnosis of tumor tissues, the formation was determined to be hormone-dependent (hormone therapy is ineffective in small cell prostate cancer), the oncologist prescribes a number of hormonal drugs. Hormone therapy is aimed at neutralizing the influence of hormones secreted by the testes and adrenal glands. Removal of the testicles, as a method of hormonal treatment of prostate cancer, is used in Israel in very rare cases, with the consent of the patient, with unwillingness or impossibility to take hormonal drugs.

Cryotherapy

Cryotherapy is the effect of low temperatures on a cancerous tumor. Under the influence of cold, cancer cells are destroyed. Cryotherapy is a minimally invasive technique, so it is quite easily tolerated by patients. It is recommended in cases where, due to age or other factors related to the specifics of the patient's body, surgical techniques are contraindicated. This technique is almost never used today, due to the large number of relapses.

Chemotherapy

The role of an additional method of treating prostate cancer in rare cases is performed by chemotherapy, when the main types of therapy were ineffective. Chemotherapy drugs can kill cancer cells or stop them from growing and multiplying.

Chemotherapy in Israel in the treatment of prostate cancer is used at a late stage, or in the case of small cell prostate cancer. The goal of the oncologist in this case is to maximize the life of the patient and achieve the least side effects. In Prof. Sela's practice, there are many successful cases with a life expectancy of over 10 years, with an initial diagnosis of stage 4 prostate cancer!

Is it always necessary to treat prostate cancer in Israel?

In rare cases, prostate cancer does not require treatment and requires only constant monitoring. If a small tumor is found in an elderly person (after 85 years) or in a patient with concomitant diseases, there is no need to resort to heavy treatment. A cancerous tumor in the prostate is characterized by slow growth and therefore in some cases does not affect life expectancy.

Contact us regarding the treatment of prostate cancer in Israel and be sure that the best specialists in the country will deal with you, and the organization of treatment will be carried out as soon as possible.

Prostate cancer treatment in Israel

When a man is first diagnosed with prostate cancer, an Israeli clinic will offer him a choice of several treatment options. What factors should be considered before making a decision?

Identification of risk groups

Most men develop so-called localized prostate cancer. This means that the pathology is at an early stage and has not spread beyond the gland. While some patients can live long lives and end up dying from something other than cancer - even in the absence of any treatment - in others, the disease is often much more aggressive and therefore requires more aggressive therapy.

The following clinical parameters are used to divide patients into risk groups and thereby determine oncological tactics:

• serum PSA level;
• Gleason index based on biopsy results;
• Disease prevalence as assessed clinically, from rectal examination and imaging studies.

Based on these parameters, we build a prediction system, in accordance with which a therapy plan is developed. Consult TopClinic

Diagnosis of prostate cancer in Israel: the latest developments

In some cases, prostate cancer is characterized by a high risk and aggressive course, and in other cases, a less likely outcome. A biopsy reveals a malignant tumor, but diagnostic tools provide minimal information about the degree of aggressiveness of the disease. Therefore, most men decide to immediately begin treatment. At the end of therapy, many patients experience serious side effects for a long time.

Immediate treatment is not always necessary, but there is currently no way to know if action should be taken immediately or if treatment can be delayed.

Now Israeli scientists are developing an innovative test to answer this question. By analyzing primary tumor biology and using genes from a variety of biological pathways, the test predicts the aggressiveness of prostate cancer at the time of diagnosis, allowing men to make more informed treatment decisions with confidence.

Prostate cancer tests may include:

• Digital rectal examination (DRE). During DRE, the doctor inserts a lubricated index finger into the rectum to examine the prostate. If any abnormalities are found in the structure, shape, or size of the gland, you may need further tests.
• Prostate specific antigen (PSA). A blood sample is taken from a vein in your arm and tested for PSA. PSA is a tumor marker that is naturally produced by your prostate gland. It is normal for a small amount of PSA to be in your bloodstream. However, if a higher than normal level is found, then this may indicate a prostate infection, inflammation, enlargement, or cancer.

PSA analysis combined with PRI helps to detect prostate cancer at the earliest stages. Consequently, the debate continues around prostate cancer screening. Find out the price of diagnostics

How is a prostate cancer screening done?

If the DRE or PSA test finds an abnormality, further tests will be recommended to determine if you have prostate cancer, for example:

• Ultrasound. If other tests are of concern, your doctor may use a transrectal ultrasound (TRUS) to further evaluate your prostate. A small tube the size of a cigar is inserted into the rectum. The probe uses sound waves to create an image of your prostate.
• Prostate tissue sample collection. If the initial test results indicate prostate cancer, your doctor may recommend a procedure to collect a sample of cells from your prostate (prostate biopsy). A biopsy of the prostate is often done using a thin needle that is inserted into the prostate to collect tissue. A tissue sample is analyzed in a laboratory to determine if cancer cells are present.

At TopClinic clinics, urologists and radiologists collaborate on the use of MRI-assisted biopsy technology, which provides the best fusion picture available for the treatment of prostate cancer.

When a biopsy confirms the presence of cancer, the next step is to determine the aggressiveness (grade) of the cancer cells. A laboratory pathologist examines a sample of your cancer to determine how many cancer cells differ from healthy cells. A higher level of aggressiveness indicates a cancer that will spread quickly.

The most common scale used to evaluate prostate cancer cell levels is called the Gleason score. The Gleason score combines two numbers and can range from 2 (non-aggressive cancer) to 10 (very aggressive cancer).

In addition, genomic testing is increasingly being used to more accurately assess risk and detect aggressive prostate cancer.

Treatment tactics for patients with prostate cancer

According to the results of research, Israeli oncologists divide patients with prostate cancer into 3 risk groups for progression of the pathology:

Low Risk Group

If the patient is at very low risk for disease progression, active surveillance is recommended. This means that the patient will have to regularly come for examinations and take tests for PSA levels. If necessary, a biopsy is ordered. If prostate cancer has begun to progress, more aggressive methods are required.

In certain cases, low-risk patients can choose between active surveillance, radiotherapy, and radical prostatectomy.

Moderate risk group

Patients with moderate-risk pathology should not rely on active surveillance. Basically, they choose between radiation therapy and surgery. When choosing radiotherapy, they are also prescribed a course of androgen deprivation therapy for 6 months.

High risk group

Patients with high-risk tumors are threatened by the rapid progression of the disease and the occurrence of metastases. They are most often prescribed a prostatectomy. If the patient refuses the operation in favor of radiation exposure, he will have to undergo an additional 2 or 3 years of androgen deprivation therapy. Find out the cost of prostate treatment

Surgery or radiotherapy?

The criteria for choosing between surgery and radiation depend on the patient's risk profile. If the patient is contraindicated for surgery due to any other comorbidities or risk factors - for example, heart disease, diabetes, or simply old age - most likely, he will be prescribed radiation with or without concurrent hormonal therapy.

A younger patient - say 50-55 years of age - who is in good physical shape and does not suffer from other diseases, except for a very aggressive prostate tumor, the doctor will recommend immediate surgery. According to patients, minimally invasive surgery for prostate cancer by a qualified specialist is the best way to solve the problem.

With regard to surgery, it is very important to preserve the nerves that mediate sexual function to ensure an optimal quality of life. Therefore, the question arises before the surgeon: can he preserve these nerves and at the same time remove all traces of the pathology? The specialist discusses this issue with the patient before the procedure. Depending on the degree of risk, the doctor may also have to remove the lymph nodes in the pelvic area, which can cause swelling later.

If the doctor damages the sphincter of the bladder during surgery, the patient may develop urinary incontinence after surgery.

Most of the listed side effects go away with time. If you look at the results of various scientific studies, 30 to 50% of patients report a decrease in the intensity of side effects 2 years after surgery. It should be noted, however, that these adverse events are not initially severe. For example, sickle cell dysfunction is treated with implantation and drug therapy.

Patients who treat prostate cancer with radiation suffer from more severe side effects. These include irritable bowel syndrome, because the intestine, like the prostate, is included in the irradiation field.

Symptoms of irritable bowel syndrome are:

• imperative urge to defecate;
• diarrhea;
• rectal bleeding.

However, these side effects disappear within 1-2 years after treatment.

The phenomena associated with the function of the urinary tract are caused by the so-called radiation cystitis. Patients complain of frequent urge to urinate and a burning sensation, but all this passes with time.

Sexual dysfunction is a side effect that increases during the 1st year or 2 years after exposure. However, in most cases, the side effects observed after 2 years after the end of radiation therapy are almost the same as the undesirable consequences of surgery. Therefore, the choice of treatment method depends on the presence or absence of concomitant diseases.